John Haanen

基本信息

Career Trajectory

Bio

In 2001, I started my own research group and worked on development of novel vaccination and cellular strategies for the treatment of cancer, all of which were translated to clinical trials.

Outside of NKI and LUMC, I have been chair of the Working Party Immunotherapy for Oncology from 2008 – 2016. Within ESMO, I fulfilled the position of scientific chair of the ESMO IO meeting from 2016-2019, was scientific chair of the ESMO 2020 annual meeting, and I am Editor-in-Chief of ESMO Journal IOTECH, starting in 2018.

Research Interests

Papers共 661 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

An Update on Access to Novel Treatment for Metastatic Melanoma in Europe — A 2024 Survey of the European Melanoma Registry and the European Association of Dermato-Oncology

L. Kandolf,P. A. Ascierto,L. Bastholt, I. Gavrilova,J. Haanen,A. Hauschild,D. Herceg,C. Hoeller, A. Jalovcic Suljevic, Ji Kessels,I. Krajsova,M. Kukushkina,A. Lallas,P. Lorigan,J. Mangana,I. Marquez-Rodas, L. Mazilu,P. Mohr, M. Bylaite-Bucinskiene,J. Ocvirk, J. Olah, K. Putnik, P. Rutkowski, P. Saiag, I. Samolyenko, J. K. Schwarze, I. Stojkovski, N. Cicmil Saric, R. Vieira, M. Weichenthal, C. Garbe

EUROPEAN JOURNAL OF CANCER (2025)

Cited0Views0WOSBibtex

Body Composition and Checkpoint Inhibitor Treatment Outcomes in Advanced Melanoma: a Multicenter Cohort Study

Journal of the National Cancer Institute (2025)

Cited0Views0WOSBibtex

Baseline and on Treatment Biodistribution Variability of 18F-FLT Uptake in Patients with Advanced Melanoma: Brief Communication

Bernies van der Hiel,Else A. Aalbersberg,Alfons J. M. van den Eertwegh, Jitha Fischer,Ronald Boellaard,Filip Y. F. L. de Vos,Marye J. Boers-Sonderen,Marcel P. M. Stokkel,Linda J. de Wit- van der Veen,John B. A. G. Haanen

Clinical Nuclear Medicineno. 8 (2024): 722-726

Cited0Views0WOSBibtex

Advanced Stage Melanoma During Pregnancy: Real-world Management

Jessica S. W. Borgers,Douglas Buckner Johnson,Elisabeth Livingstone,Elizabeth Iannotti Buchbinder,William A. Robinson,Omid Hamid, Michelle Ferreira,Florentia Dimitriou,Georgina V. Long,Paolo Antonio Ascierto, Antonios Daletzakis,Yana G. Najjar,Geke Hospers, Jacob Seung Choi,Frederic Amant,Katy K. Tsai,Zeynep Eroglu,John Haanen,Isabella Claudia Glitza

Journal of Clinical Oncologyno. 16_suppl (2024): 9540-9540

Cited0Views0Bibtex

292P Avelumab + Axitinib (A + Ax) Vs Sunitinib (S) in Patients (pts) with Advanced Renal Cell Carcinoma (arcc): Subgroup Analyses by Age from the Final Analysis of the Phase III JAVELIN Renal 101 Trial

M. Oya,R.J. Motzer,T.K. Choueiri,J.B.A.G. Haanen,M. Eto,H. Uemura,B. Venugopal,B.I. Rini,H. Miyake,L. Albiges,M. Schmidinger,Y. Tomita,Y. Umeyama,B. Ellers-Lenz, J. Hoffman,J. Larkin

Annals of Oncology (2024): S1517-S1518

Cited0Views0Bibtex

Tumour-infiltrating Lymphocyte Therapy for Patients with Advanced-Stage Melanoma

Sebastian Klobuch,Tom T. P. Seijkens,Ton N. Schumacher,John B. A. G. Haanen

Nature Reviews Clinical Oncologyno. 3 (2024): 173-184

Cited4Views0WOSNATUREBibtex

ESMO Resilience Task Force Recommendations to Manage Psychosocial Risks, Optimise Well-Being, and Reduce Burnout in Oncology

K. H. J. Lim,K. Kamposioras, E. Elez,J. B. A. G. Haanen,C. Hardy,K. Murali,M. O'Connor,C. Oing,K. Punie,E. de Azambuja,J. Y. Blay,S. Banerjee

ESMO OPENno. 10 (2024)

Cited0Views0WOSBibtex

Subgroup Analyses of Efficacy Outcomes by Baseline Tumor Size in the Phase 3, Open-Label CLEAR Trial

Viktor Grunwald,Robert J. Motzer,John B. A. G. Haanen,Manuela Schmidinger,Michael D. Staehler,Jeffrey C. Goh,Eric Voog,Miguel Angel Climent,Saby George,Joseph E. Burgents,Ran Xie,Jodi Mckenzie,Camillo Porta

Journal of Clinical Oncologyno. 4_suppl (2024): 364-364

Cited0Views0Bibtex

611O Updated Results from BNT211-01 (NCT04503278), an Ongoing, First-in-human, Phase I Study Evaluating Safety and Efficacy of CLDN6 CAR T Cells and a CLDN6-encoding Mrna Vaccine in Patients with Relapsed/refractory CLDN6+ Solid Tumors

J.B.A.G. Haanen,A. Mackensen,C. Schultze-Florey,W. Alsdorf,E. Wagner-Drouet,D. Heudobler,P. Borchmann,A. Busse, S. Mielke,S. Bins, G. Ungerechts,C. Bokemeyer,S. Klobuch,N. Kutsch, F. Müller,A. Desuki, W. Zhong,L. Preussner,Ö. Türeci,U. Sahin

Annals of Oncology (2024): S489-S490

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Group Leader

Papers共 661 篇Author StatisticsCo-AuthorSimilar Experts